TransMedics Group, Inc. (TMDX)

TransMedics Group, Inc. (TMDX) is a healthcare company (medical devices) based in the United States. The share price is $94.87, up 2.88% on the day, which values the company at $3.3B. Price as of 17 Nov 2026, 17:38 UTC, from Yahoo Finance.

Key facts

Share price
$94.87+2.88% today
Market value
$3.3B
P/E ratio
25.9×last 12 months
Forward P/E
38.2×
Funk Score
81/100
Against its own history
Well below its usual priceusual price $159.04
200-week average
$96.352% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

TransMedics Group, Inc. in more detail

TMDX trades at 25.9× its last twelve months' earnings, 38.2× next year's expected earnings, 4.5× sales. Measured against its own history, the price is 40% below what its usual multiples would imply ($159.04) — well below its usual price. It sits 2% below its 200-week average of $96.35.

Over the last five fiscal years TransMedics Group, Inc. has compounded revenue 84.5% a year. Its Funk Score is 81 out of 100 (financial strength 6.6, profitability 7.4, growth 10.0, value 8.2, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Beneish M-score flags the accounts; Share count keeps rising.

TransMedics Group, Inc. (TMDX): questions and answers

What is TMDX's P/E ratio?

TransMedics Group, Inc. trades at 25.9× its last twelve months' earnings and 38.2× next year's expected earnings.

What is TMDX's PEG ratio?

TransMedics Group, Inc.'s PEG ratio is 0.91 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is TransMedics Group, Inc.'s market cap?

TransMedics Group, Inc. is valued at $3.3B at a share price of $94.87.

Is TMDX overvalued or undervalued?

Against its own history, TMDX is well below its usual price: the price is 40% below the $159.04 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is TMDX above its 200-week moving average?

No. TMDX is 1.5% below its 200-week average of $96.35. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is TransMedics Group, Inc. growing?

Over the last five fiscal years TransMedics Group, Inc.'s revenue grew 84.5% a year.

Cite this page

Funkfolio, “TransMedics Group, Inc. (TMDX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/TMDX

Underlying data: Yahoo Finance; company filings with the SEC.